Association and interaction of blood homocysteine and p‐tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Qiang Wang und 32 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Homocysteine, tau Proteins, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Key Areas Research and Development Programs-Brain Science and Brain-Inspired Intelligence Technology, Industry-University-Research Innovation Fund for Chinese Universities, Guangzhou Key Research and Development Program.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The relationships between blood homocysteine (Hcy), amyloid beta (Aβ), tau pathology, and their combined effects on cortical thinning and cognitive impairment in Alzheimer's disease (AD) remain poorly understood. METHODS Participants were stratified into Aβ+ and Aβ− groups by positron emission tomography. Blood levels of Hcy, AD biomarkers (phosphorylated tau‐217 [p‐tau217], p‐tau181, and Aβ), cortical thickness (via magnetic resonance imaging), and cognitive performance were assessed. RESULTS Aβ+ individuals exhibited increased blood Hcy and p‐tau217 levels, which negatively correlated with temporal cortical thickness and cognitive function. A significant interaction between Hcy and p‐tau217 was observed in Aβ+ participants, with high Hcy exacerbating the detrimental effects of p‐tau217 on temporal cortical thinning and cognitive deficits. In Aβ− individuals, Hcy levels were independently associated with tau pathology. DISCUSSION Increased Hcy and p‐tau217 levels synergistically contribute to cortical thinning and cognitive impairment, highlighting that Hcy may be a modifiable risk factor for AD progression. Highlights Increased blood levels of homocysteine (Hcy) and phosphorylated tau‐217 (p‐tau217) are independently and interactively associated with temporal cortical thinning and cognitive deficits. Hcy may predominantly affect tau pathology compared to amyloid aggregation, with its impact on neurodegeneration depending on coexisting pathologies. Hcy may serve as a supplementary indicator rather than as an independent predictor in Alzheimer's disease. Hcy may serve as a modifiable risk factor, whereas p‐tau217 as a superior diagnostic biomarker and potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China.
- Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, Guangdong Province, China.
- Departments of Nuclear Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
- State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Secondary Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China.
Förderung
- Guangdong Province Key Areas Research and Development Programs-Brain Science and Brain-Inspired Intelligence Technology
- Industry-University-Research Innovation Fund for Chinese Universities
- Guangzhou Key Research and Development Program
- Guangzhou Traditional Chinese Medicine and Integrated Traditional Chinese and Western Medicine Science and Technology Project
- Basic and Applied Basic Research Project of Guangzhou Basic Research Program
- Guangzhou Science and Technology Plan Project
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province China
Zitieren
APA
Wang, Q., Zhong, X., Gao, P., Xiao, Z., Chen, B., Tan, H., Liu, Q., Yao, K., Liang, S., Li, J., Yang, M., Xu, D., Lin, G., Wu, Z., Shi, H., Zhang, M., Shi, X., Liu, H., Zeng, Y., …, & Zhou, H. (2025). Association and interaction of blood homocysteine and p‐tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70465
Vancouver
Wang Q, Zhong X, Gao P, Xiao Z, Chen B, Tan H, et al. Association and interaction of blood homocysteine and p‐tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70465
BibTeX
@article{Wang2025,
author = {Wang, Qiang and Zhong, Xiaomei and Gao, Pengbo and Xiao, Zhidai and Chen, Ben and Tan, Haoye and Liu, Qin and Yao, Kexin and Liang, Shuang and Li, JiaFu and Yang, Mingfeng and Xu, Danyan and Lin, Gaohong and Wu, Zhangying and Shi, Haishan and Zhang, Min and Shi, Xiaolei and Liu, Huanmin and Zeng, Yijie and Chen, Yunheng and Lin, Yicheng and Zhang, Shuwei and Ouyang, Cong and Tian, Shihan and Gan, Yujing and Zeng, Mingyong and Lv, Jieqin and Liang, Xiang and Cheng, Yuwang and Guo, Jianwen and Ran, Pengcheng and Ning, Yuping and Zhou, Huarong},
title = {Association and interaction of blood homocysteine and p‐tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70465}
}
EUVIMED